Clinical trial
Safety, Tolerability, and Efficacy of Deferasirox in MDS
NCT00469560 · Gruppo Italiano Malattie EMatologiche dell'Adulto, Other · Completed
Key facts
| NCT number | NCT00469560 |
|---|---|
| Title | Safety, Tolerability, and Efficacy of Deferasirox in MDS |
| Official title | Open Label, Multicenter Study to Evaluate Safety/Tolerability and Efficacy of Deferasirox (ICL670) in Myelodysplastic Syndrome Patients With Chronic Transfusional Hemosiderosis. |
| Lead sponsor | Gruppo Italiano Malattie EMatologiche dell'Adulto, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Myelodysplastic Syndromes, Hemosiderosis |
| Intervention type | Drug |
| Interventions | Deferasirox |
| Enrollment | 158 |
| Start date | Jun 1, 2007 |
| Primary completion | Mar 1, 2010 |
| Completion | Nov 1, 2013 |
| First posted | May 4, 2007 |
| Last update posted | Nov 22, 2016 |
| Countries | Italy |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: